Eastwood Bio-Medical Canada Inc Cash Flow Reinvestment Rate

Latest as of April 2026: 0.00x

Eastwood Bio-Medical Canada Inc cash flow reinvestment rate. Eastwood Bio-Medical Canada Inc (EBM) has a Cash Flow Reinvestment Rate of 0.00x as of April 2026, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$2.26K. Explore Eastwood Bio-Medical Canada Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

CA$0.00
Capex + Investments

Operating Cash Flow

CA$2.26K
CAD

Capital Expenditures

CA$0.00
CAD

Cash Flow Reinvestment Rate of Eastwood Bio-Medical Canada Inc (2014–2025)

Cash flow reinvestment rate of Eastwood Bio-Medical Canada Inc from 2014 to 2025. Historical reinvestment intensity for Eastwood Bio-Medical Canada Inc across 2 annual periods. Explore capital reinvestment ratio of Eastwood Bio-Medical Canada Inc to see what proportion of operating cash flow is directed to capital expenditures.

Eastwood Bio-Medical Canada Inc Cash Flow Reinvestment Rate by Year (2014–2025)

Eastwood Bio-Medical Canada Inc cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for Eastwood Bio-Medical Canada Inc. For the full cash flow conversion analysis, see Eastwood Bio-Medical Canada Inc operating cash flow efficiency.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2025 0.00x CA$0.00 CA$19.30K CA$0.00 ▼ -100.0%
2014 0.35x CA$550.00K CA$1.58 Million CA$0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow